GLP-1 for Menopause: Weight Loss, HRT, Side Effects and What to Expect

Menopause changes how your body stores fat, handles blood sugar, and responds to food. If your waistline keeps growing, or the scale won't budge even though you're doing everything "right," that is biology, not a willpower problem. GLP-1 medications like semaglutide and tirzepatide have become one of the most talked-about options, and women are asking very specific questions: Do they work in perimenopause? Can I take them with HRT? Will they help my belly? Will insurance pay?

This guide answers those questions with the best evidence available today, including the places where the evidence is still thin. If you're ready to compare programs and prices, see our directory of GLP-1 telehealth providers.

GLP-1 for Menopause Weight Loss: Does It Work?

For most women who qualify, yes. GLP-1 medications are not a menopause treatment, because they don't replace estrogen. They work on appetite, fullness, and blood sugar, which are the systems that often shift during the transition.

The strongest midlife-specific data come from a post hoc analysis of the SURMOUNT trials that included 2,542 women. Researchers sorted participants by reproductive stage and found that tirzepatide worked at every stage:

In every stage, 97% to 98% of women on tirzepatide lost at least 5% of their body weight. Semaglutide has strong results too: the 2021 trial that led to Wegovy's approval reported an average loss of about 15% after 68 weeks.

A few caveats are worth knowing. This was a post hoc analysis (the groups weren't planned in advance), it was funded by the drugmaker, and participants had overweight or obesity without type 2 diabetes. Averages also hide a wide range, so your own results may be higher or lower.

Who Can Use a GLP-1 for Weight Loss?

The weight-loss versions are FDA-approved for adults with obesity (a BMI of 30 or higher), or overweight (a BMI of 27 or higher) with at least one weight-related condition such as high blood pressure, high cholesterol, or sleep apnea. You do not need a diabetes diagnosis. No GLP-1 is FDA-approved specifically for menopause.

GLP-1 Menopause Benefits Beyond the Scale

Weight is only part of the story. In the 2024 semaglutide study described below, postmenopausal women who used hormone therapy also improved their HbA1c (a blood sugar marker), triglycerides, and total cholesterol over 12 months. For women whose blood sugar and cholesterol drift in the wrong direction after menopause, those changes can matter as much as the number on the scale.

Why Menopause Weight Gain and Belly Fat Are So Hard to Lose

Visceral Belly Fat in Perimenopause: What Hormone Shifts Do

Falling estrogen changes where your body stores fat. Many women notice weight settling around the abdomen even when their eating and exercise haven't changed. Research links the loss of estrogen to more visceral fat, the deep abdominal fat that surrounds the liver and intestines. Visceral fat is metabolically active and promotes low-grade inflammation, which is why it raises the risk of:

• Type 2 diabetes
• Cardiovascular disease
• Fatty liver disease (MASLD)
• High blood pressure

To learn more about how falling estrogen affects the rest of your body, see our article on estrogen deficiency and your body and brain.

Midlife Insulin Resistance

Estrogen also influences how your body responds to insulin. As it declines, cells can become less sensitive to insulin, which makes it easier to store fat and harder to lose it. This is one of the main reasons a medication that improves insulin sensitivity and blood sugar control can help in midlife.

It's Not Just Calories

Several things shift at the same time during the transition:

• Appetite hormones: Estrogen interacts with the hormones that signal hunger and fullness, including GLP-1 itself.
• Sleep: Hot flashes and night sweats fragment sleep, and poor sleep disrupts the hormones that regulate hunger.
• Muscle: Muscle mass declines faster in midlife. Muscle burns more calories at rest than fat, so losing it lowers your metabolic floor.
• Energy use: Resting metabolic rate drifts down with age.

The bottom line: midlife weight gain isn't a failure of willpower. It is a predictable hormonal and metabolic event. You can estimate your own numbers with our BMR calculator.

Can a GLP-1 Help With Menopause Belly Fat?

It can. In the SURMOUNT analysis, waist circumference fell more with tirzepatide than with placebo at every reproductive stage. In the head-to-head SURMOUNT-5 trial, waist circumference also dropped more with tirzepatide than with semaglutide. Weight loss isn't targeted to one area, but a shrinking waist is a good sign that you're losing the kind of fat that matters most for health.

Best GLP-1 for Menopause Weight Loss: Semaglutide vs. Tirzepatide

There isn't one best GLP-1 for every woman. Here is how the main weight-loss options compare in major trials:

Each result comes from a different trial, so don't compare the numbers directly. Only Zepbound and Wegovy have been tested head to head.

Semaglutide vs. Tirzepatide for Weight Loss

The one head-to-head trial, SURMOUNT-5, compared the two injections at their maximum doses over 72 weeks. Tirzepatide produced an average loss of 20.2% of body weight, compared with 13.7% for semaglutide. Both are very effective, and the lead investigator noted that clinicians should individualize the choice. Most women aren't at the same dose or on the same schedule as trial participants, so "best" depends on more than a headline number.

How to Choose Between GLP-1 Medications

• How much weight you want to lose: Tirzepatide has produced larger average losses, which may matter if you have a lot to lose.
• Side effects: Nausea and other digestive effects happen with all of them. Tolerability is personal.
• Injection or pill: Weekly injections and daily pills now both exist for weight loss.
• Your HRT or birth control: Tirzepatide has a documented effect on oral contraceptive absorption, which may be relevant to oral hormones. See the HRT section below.
• Cost and coverage: What you can get covered or afford often decides the medication. See insurance and cost.
• Your health history: Some conditions rule out GLP-1s entirely (see side effects and safety).

FDA-Approved GLP-1 Medications at a Glance

These medications have been in clinical use for two decades. What's new is who is using them and how much they help. Note that Ozempic and Mounjaro are approved for type 2 diabetes, while Wegovy, Zepbound, Saxenda, and Foundayo are approved for weight management. Prescribers may use clinical judgment when prescribing outside the approved use, which is called off-label prescribing.

Are There GLP-1 Pills?

Yes, and the answer has changed recently. The Wegovy pill was approved in December 2025, and Foundayo, a once-daily pill that can be taken without food or water restrictions, was approved in April 2026. Rybelsus, the older oral semaglutide, is approved for type 2 diabetes and has stricter timing rules. Ask your prescriber which pill, if any, fits your goals.

Can You Take GLP-1 and HRT Together?

In general, yes. Taking a GLP-1 with menopausal hormone therapy is common, and there is no established reason they can't be combined. The more interesting question is whether HRT improves the results, and early research suggests it might.

Semaglutide and HRT: What the Research Shows

A 2024 study in Menopause looked back at 106 postmenopausal women who took semaglutide for weight loss. Sixteen women also used hormone therapy. At 12 months, the women on hormone therapy had lost about 16% of their body weight, compared with about 12% for those who didn't use it, and the gap showed up at every checkpoint measured.

Tirzepatide and HRT: The Mayo Clinic Study

A Mayo Clinic study published in The Lancet Obstetrics, Gynaecology & Women's Health compared 40 postmenopausal women who used hormone therapy with 80 who didn't. All had taken tirzepatide for at least a year. The hormone therapy group lost an average of 19.2% of their body weight, compared with 14.0% in the other group, which works out to about 35% more weight lost in relative terms.

Both studies were observational and small, and the combination hasn't yet been tested in a randomized trial. The senior author, Dr. Maria Daniela Hurtado Andrade, was clear that the results can't show HRT caused the extra weight loss. Randomized trials are the next step.

Why Might HRT Help GLP-1s Work Better?

Researchers are still working out the explanation. Possibilities include:

• Laboratory research suggests estrogen may enhance the appetite-suppressing effects of GLP-1-based medications
• Treating hot flashes and night sweats can improve sleep, and better sleep supports healthier hunger signals
• Estrogen helps preserve lean muscle, which matters when you're losing weight
• Feeling better overall may make it easier to stick with nutrition and activity changes

Semaglutide and HRT in Perimenopause

Most of the combination research was done in postmenopausal women, so there is less direct evidence for perimenopause. Tirzepatide worked about as well in perimenopausal women as in others, but whether adding HRT boosts the effect during perimenopause hasn't been studied the same way. If you're perimenopausal and considering both, the decision should rest on your symptoms and health history. Our HRT 101 Guide covers the basics.

Does HRT Interfere With GLP-1 Weight Loss?

There is no evidence that it does. If anything, the studies above point the other way. The one real concern is practical rather than hormonal, and it involves how oral medications are absorbed.

Taking Tirzepatide With an Estrogen Patch (and Other HRT Routes)

GLP-1 medications slow gastric emptying, meaning food and pills leave your stomach more slowly. That can change how well oral medications are absorbed. With tirzepatide, the effect is documented: after a single dose, manufacturer data showed the peak level of an oral birth control pill dropped by 55% to 66%, and total exposure fell by 16% to 23%. Semaglutide hasn't shown a clinically relevant effect on oral contraceptives.

No one has studied this specifically for oral HRT. As a precaution, the British Menopause Society issued guidance in 2025 that suggests:

• Transdermal estrogen (patch or gel) is preferred for women on GLP-1s, because it bypasses the stomach. If you already use a patch, nothing needs to change.
• Progesterone needs extra attention if you take it by mouth. If you have a uterus and take estrogen, you need progesterone to protect the uterine lining. Options include temporarily increasing the oral dose for four weeks after starting a GLP-1 and after each dose increase, using a hormonal IUD, or switching to vaginal progesterone. There are no data on how much to increase the dose, so your prescriber should decide.
• Report unexpected bleeding. Bleeding on HRT that you didn't expect should be evaluated, especially while changing GLP-1 doses.

Don't adjust your hormones on your own. Bring this to your prescriber, ideally one who is comfortable with both therapies. If you're still using oral birth control in perimenopause, tirzepatide's manufacturer advises switching to a non-oral method or adding a barrier method for four weeks after starting and after each dose increase. You can still get pregnant in perimenopause, and weight loss can sometimes make cycles more regular.

Learn more in our guides to estradiol and progesterone dosing and progesterone intolerance.

Semaglutide During Perimenopause: Weight Loss and Microdosing

Perimenopause is when many women first notice stubborn weight gain, often before periods stop. Semaglutide can help, and the same safety points apply as at any other stage. Two perimenopause-specific points are worth highlighting. First, pregnancy is still possible, and GLP-1 medications shouldn't be used during pregnancy, so talk to your prescriber about contraception. Second, perimenopausal symptoms like night sweats, mood swings, and fatigue can overlap with medication side effects, which can make it hard to tell what's causing what.

Microdosing Semaglutide for Perimenopause Weight Gain

"Microdosing" usually means taking a much smaller amount than the FDA-approved dose, most often with compounded semaglutide. It is popular online, but the evidence doesn't support it yet:

• It is not an FDA-approved dosing strategy, and no large clinical trials show it works for weight loss
• Splitting doses or counting pen clicks can lead to dosing errors
• The FDA has raised concerns about dosing errors, improper storage, and mislabeled products from some compounding pharmacies

It's different if your prescriber recommends a slower dose increase or a lower maintenance dose to manage side effects. That is a clinical decision made for you, with an approved product and a dosing plan you understand. If a provider offers microdosing, ask what product they use, how it's dosed, and what evidence they rely on. Our GLP-1 telehealth directory lists providers that advertise it, so you can ask these questions before you commit.

GLP-1 and Menopause Symptoms: Hot Flashes, Mood Swings and Sleep

It's reasonable to hope that a medication that helps with weight might help with other menopause symptoms. The honest answer is that GLP-1s weren't designed for them, and the evidence is limited.

GLP-1 and Menopause Hot Flashes

Mayo Clinic describes hormone therapy as the most effective first-line treatment for hot flashes and night sweats. GLP-1 medications don't replace it. If hot flashes are your main problem, see our comparison of Veozah vs. HRT. If hot flashes seem to worsen after you start a GLP-1, tell your prescriber. Eating too little or becoming dehydrated can make heat symptoms feel worse, and some women simply notice symptoms more once perimenopause is underway.

Does Semaglutide Affect Menopause Mood Swings?

We don't have good data on this in menopausal women. Mood changes during the transition are driven by shifting hormones, poor sleep, and stress, and weight loss can bring both relief and new stressors. Report any new or worsening anxiety, low mood, or changes in how you feel to your provider rather than waiting it out.

Why Am I Not Losing Weight on a GLP-1 in Menopause?

Weight loss on a GLP-1 isn't a straight line. Many people see a fast drop early, then a plateau. Before you assume the medication isn't working, it helps to look at the common reasons progress stalls in midlife.

Why Am I Not Losing Weight on Semaglutide in Menopause?

In the head-to-head trial, average weight loss with semaglutide was lower than with tirzepatide, and individual responses varied widely with both. Some women plateau on semaglutide and do better on a different medication, but that is a decision for you and your prescriber. Don't raise your dose on your own, and be cautious about unverified products if your results seem off.

A symptom and habit log can also reveal patterns your provider can use. Our protein calculator and daily goals tool are good places to start.

GLP-1 Side Effects During Perimenopause and Menopause

Common Side Effects

Most side effects are digestive and tend to be strongest when you start or increase the dose. They usually ease with time.

• Digestive symptoms: nausea, vomiting, bloating, diarrhea, constipation, and sometimes acid reflux
• Reduced appetite: part of how they work, but it can make it hard to get enough nutrition
• Fatigue: especially in the first few weeks
• Hair shedding: reported with rapid weight loss, which can add to the hair changes many women already notice in midlife

Less Common but Serious Side Effects

• Pancreatitis: seek care for persistent, severe abdominal pain
• Gallbladder problems: rapid weight loss of any kind raises gallstone risk
• Faster resting heart rate: some people notice a small increase
• Thyroid C-cell tumors: seen in animal studies, so GLP-1s aren't used in people with a personal or family history of medullary thyroid carcinoma or MEN2
• Low blood sugar: mainly a concern when combined with insulin or sulfonylureas

Who Should Use Caution or Avoid GLP-1s

• A personal or family history of medullary thyroid carcinoma or MEN2 syndrome
• A history of pancreatitis
• Severe gastrointestinal motility disorders
• Pregnancy or breastfeeding, or planning pregnancy
• A history of eating disorders, which should be discussed carefully with a provider

Stopping a GLP-1

Real-world studies suggest many people stop within the first year or two, and weight typically returns after stopping, often as fat rather than muscle. That is a particular concern when muscle and bone are already declining. If you and your provider decide to stop, ask for a transition plan that includes strength training, protein-focused eating, and a conversation about HRT.

Muscle Loss on GLP-1s: Strength Training and Protein for Midlife Women

Weight loss of any kind can take muscle along with fat, and GLP-1s are no exception. A meaningful share of the weight lost can be lean mass, though estimates vary widely between studies. This matters more after menopause for several reasons:

• Metabolism: less muscle means a lower resting metabolic rate and a higher chance of regaining weight
• Bone health: muscle loading is one of the signals that helps maintain bone density
• Independence: strength and balance matter for aging well

A 2025 RAND analysis raised muscle loss as an under-studied concern for women using GLP-1s in perimenopause. Because estrogen supports lean mass, HRT may help, though this hasn't been proven in GLP-1 users.

How to Protect Your Muscle

• Lift 2 to 3 times a week, working the major muscle groups
• Prioritize protein at every meal. A common target is 1.2 to 1.6 grams per kilogram of body weight daily, but check specifics with a registered dietitian. Use our protein calculator and high-protein foods list
• Eat enough. A suppressed appetite makes it easy to under-fuel, which speeds muscle and bone loss
• Ask about bone density. Discuss a baseline bone density (DEXA) scan before you start, and learn about osteoporosis prevention
• Ask about HRT if you're not already using it

Learn more about HRT in our Complete HRT Guide for Menopause & Perimenopause.

Joint and muscle aches can also change as your weight and activity do. See our guide to midlife aches and the musculoskeletal syndrome of menopause.

Eating Right on GLP-1 Medications

GLP-1s reduce how much you want to eat, sometimes dramatically. That is the point, but eating too little, or eating low-quality food in small amounts, can speed muscle and bone loss and leave you nutritionally depleted.

• Protein first: eggs, Greek yogurt, cottage cheese, fish, poultry, legumes, tofu, and edamame. Aim for 25 to 35 grams per meal if you can, and consider shakes if whole food is hard to manage
• Fiber-rich carbohydrates: vegetables, legumes, whole grains, and low-glycemic fruit support gut health and help with constipation
• Healthy fats: salmon, olive oil, avocado, and nuts support heart health and help you absorb fat-soluble vitamins
• Bone nutrients: ask your provider whether to check your vitamin D and how much calcium and magnesium you need
• Fluids: eating less also means less water from food, and dehydration can worsen constipation and be mistaken for hunger

A registered dietitian who understands menopause and metabolic health can build an eating plan that protects your muscle and bones while you take the medication.

Will Insurance Cover GLP-1 for Menopause?

Menopause itself isn't a reason insurance covers a GLP-1. Plans that cover weight-loss medications usually look at your BMI and weight-related health conditions, and most require prior authorization. Employer plans vary a lot, and many plans exclude weight-loss drugs altogether. Medicare's rules have also been changing in 2026, so check the current terms with your plan.

Cost is where many women get stuck. Brand-name list prices are high, but manufacturer self-pay programs and telehealth providers have lowered what many people pay. Prices and promotions change often, so we keep our comparison up to date on a separate page.

If you have an HSA or FSA, see whether your medication qualifies on our FSA and HSA eligible menopause products page.

Brand-Name vs. Compounded GLP-1s

Brand-name medications are FDA-approved. Compounded versions are made by pharmacies and aren't reviewed by the FDA for safety, quality, or effectiveness. The FDA has warned about dosing errors and mislabeled products with some compounded GLP-1s. Whichever you consider, work with a licensed prescriber, ask what you're receiving and how to dose it, and be wary of anyone who skips a medical review.

Next Steps: Finding the Right Care

Finding a Weight Management Clinician

Your primary care doctor is a good first stop. Many women also use telehealth to see a board-certified obesity medicine or metabolic health provider from home. Browse our searchable database of GLP-1 telehealth providers.

Finding a Menopause Specialist

Not every gynecologist or primary care physician is current on HRT prescribing or how hormones and metabolic medications interact. A Menopause Society Certified Practitioner (MSCP) is trained specifically in this area. If your doctor brushes off your concerns, our guide on what to say when your doctor dismisses your symptoms can help.

Frequently Asked Questions About GLP-1 and Menopause

Do GLP-1 medications work for menopause weight loss?

For most women who qualify, yes. In an analysis of the SURMOUNT trials, tirzepatide produced about 23% weight loss in peri- and postmenopausal women at the highest dose, close to the 26% seen before menopause. Individual results vary widely.

Can you take GLP-1 and HRT together?

In general, yes. Observational studies of semaglutide and tirzepatide found more weight loss in women who also used HRT, though they can't prove HRT caused the difference. The route matters: transdermal estrogen is preferred, and oral progesterone needs extra attention. Work with a prescriber familiar with both.

Does HRT interfere with GLP-1 weight loss?

There's no evidence that it does. Studies suggest women on HRT lost as much or more weight. The practical concern is that GLP-1s slow stomach emptying, which could affect oral medications, so the form of HRT you take matters.

Is it safe to take tirzepatide with an estrogen patch?

Patches and gels bypass the stomach, so slowed gastric emptying shouldn't affect them. UK menopause experts prefer transdermal estrogen for women on GLP-1s. Still, confirm with your prescriber, especially if you also take oral progesterone.

Is semaglutide good for perimenopause weight loss?

It can be. Most research on semaglutide with HRT is in postmenopausal women, so there's less perimenopause-specific data. Pregnancy is still possible in perimenopause, so discuss contraception with your prescriber.

Why am I not losing weight on semaglutide in menopause?

Common reasons include a dose that's still too low, plateaus, under-eating protein and losing muscle, poor sleep from night sweats, untreated menopause symptoms, and other medications or conditions. Review the checklist above and talk with your prescriber before changing your dose.

Does a GLP-1 help with menopause belly fat?

It can. Waist circumference decreased with tirzepatide at every reproductive stage in the SURMOUNT analysis. Visceral fat is the type most closely tied to metabolic risk.

Does a GLP-1 help hot flashes?

Not as a treatment. No trials have tested GLP-1s for hot flashes or night sweats, and HRT remains the most effective first-line option. Weight loss and better sleep may help some women feel better overall.

Does semaglutide affect menopause mood swings?

We don't have solid data. Mood changes in menopause have many causes. If you notice new or worsening mood symptoms on a GLP-1, tell your provider.

What are the side effects of GLP-1s during perimenopause?

The most common are nausea, constipation, diarrhea, bloating, and fatigue, mostly when you start or increase the dose. Hair shedding can also occur. Rare but serious risks include pancreatitis and gallbladder problems.

Is microdosing semaglutide safe for perimenopause weight gain?

Microdosing isn't FDA-approved and isn't supported by large clinical trials. Dosing errors are a known risk, especially with compounded products. Ask any provider offering it what product and dosing plan they use.

Can I use a GLP-1 if I'm not diabetic?

Yes. Wegovy, Zepbound, Saxenda, and Foundayo are FDA-approved for weight management in adults with obesity, or overweight plus at least one weight-related condition. You don't need a diabetes diagnosis.

Are there GLP-1 pills for weight loss?

Yes. The Wegovy pill was approved in December 2025 and Foundayo in April 2026. Rybelsus is an older oral semaglutide approved for type 2 diabetes.

Will insurance cover a GLP-1 for menopause?

Menopause isn't a covered reason on its own. Coverage depends on your plan, your BMI, and any weight-related conditions, and prior authorization is common. See our provider and cost comparison for self-pay options.

How long will I need to take a GLP-1?

GLP-1s are generally used long term, like medications for blood pressure or cholesterol. Weight typically returns after stopping, so if you and your provider decide to stop, plan for strength training, protein-focused eating, and a conversation about HRT.

My doctor hasn't heard of combining HRT with GLP-1s. What should I do?

This is an emerging area. Consider an obesity medicine physician or a menopause specialist who follows current research, and bring the Mayo Clinic and semaglutide studies cited below to your appointment.

This article is for informational and educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider about hormone therapy, weight-loss medication, bone health, or any medical condition, and before changing your medications.

Symptom Relief

Managing menopause symptoms can feel overwhelming, especially when effective solutions seem hard to find. Explore our Symptom Relief page to discover products that other women have found helpful in managing their symptoms of perimenopause and menopause.

If you've found a product that has made a difference for you, let us know through our contact form. We'd love to share it with others!

Explore More

Want to dive deeper into menopause and its symptoms? Visit our Resources page, where you'll find a collection of studies, articles, and books from trusted experts.

Dive Deeper Into Menopause

References

1. Mayo Clinic. (2026). New study links combination of hormone therapy and tirzepatide to greater weight loss after menopause.
2. PubMed. (2024). Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use.
3. NewYork-Presbyterian. (2025). Women in menopause benefit from GLP-1 weight-loss medications as much as younger women (SURMOUNT post hoc analysis).
4. EurekAlert. (2025). Head-to-head trial compares weight loss drugs (SURMOUNT-5).
5. Healio. (2026). FDA approves orforglipron, an oral GLP-1, for adults with obesity.
6. Healthed. (2025). Concerns GLP-1s may reduce oral progesterone absorption (British Menopause Society guidance).
7. Stanford Report. (2026). What compounded GLP-1s mean for patient safety.
8. Consumer Med Safety. (2025). Errors possible when microdosing (counting clicks) to dose weight loss medicines.
9. RAND Corporation. (2025). GLP-1 agonists in perimenopause: Unique risks and potential opportunities.
10. PubMed. (2025). GLP-1 receptor agonists for weight loss for perimenopausal and postmenopausal women: current evidence.
11. Cureus. (2026). Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) for obesity and symptoms in menopause: A review.
12. PubMed. (2012). Understanding weight gain at menopause. International Menopause Society.

Support for MenoHello

If you’ve found this helpful, your support helps keep MenoHello free, independent, and focused on providing clear, trusted menopause education for women in midlife.

Support MenoHello